Altimmune, Inc. ( ALT) - Stock Earnings
ALT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
ALT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -27.4 million USD | 26000 USD |
| 2026Q1 | -22.6 million USD | — USD |
| 2026Q2 | -22.8 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ALT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -88.4 million USD | 426000 USD |
| 2024 | -95.1 million USD | 20000 USD |
| 2025 | -88.1 million USD | 41000 USD |
| 2026 Est. | — | — |
ALT
Price: $2.43
Earnings Per Share: -0.76 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 680703
Ebitda: -31.4 millionMarket Capitalization: 519.2 million